BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3162826)

  • 1. Alterations of the biological characteristics of a colon carcinoma cell line by colon-derived substrata material.
    Boyd D; Florent G; Chakrabarty S; Brattain D; Brattain MG
    Cancer Res; 1988 May; 48(10):2825-31. PubMed ID: 3162826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta.
    Chakrabarty S; Jan Y; Brattain MG; Tobon A; Varani J
    Cancer Res; 1989 Apr; 49(8):2112-7. PubMed ID: 2539253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the effects of epidermal growth factor on urokinase secretion and urokinase receptor display in a well-differentiated human colon carcinoma cell line.
    Boyd D; Brattain M
    Cancer Res; 1989 Apr; 49(8):1948-53. PubMed ID: 2539250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line.
    Levine AE; Black B; Brattain MG
    J Cell Physiol; 1989 Mar; 138(3):459-66. PubMed ID: 2925796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration in the behavior of a colon carcinoma cell line by extracellular matrix components.
    Boyd D; Florent G; Childress-Fields K; Brattain MG
    Cancer Lett; 1988 Jul; 41(1):81-90. PubMed ID: 3164644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta.
    Chakrabarty S; Tobon A; Varani J; Brattain MG
    Cancer Res; 1988 Jul; 48(14):4059-64. PubMed ID: 3289738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of the effects of epidermal growth factor on the production of urokinase and the expression of the plasminogen activator receptor in a human colon cancer cell line.
    Boyd D
    Cancer Res; 1989 May; 49(9):2427-32. PubMed ID: 2539903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of urokinase protein/transcript levels and their relationship with laminin degradation in cultured colon carcinoma.
    Boyd D; Ziober B; Chakrabarty S; Brattain M
    Cancer Res; 1989 Feb; 49(4):816-20. PubMed ID: 2912554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells.
    Zipfel PA; Ziober BL; Morris SL; Mulder KM
    Cell Growth Differ; 1993 Aug; 4(8):637-45. PubMed ID: 8398905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines.
    Boyd D; Florent G; Kim P; Brattain M
    Cancer Res; 1988 Jun; 48(11):3112-6. PubMed ID: 2835152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between extracellular matrix interactions and degree of differentiation in human colon carcinoma cell lines.
    Daneker GW; Piazza AJ; Steele GD; Mercurio AM
    Cancer Res; 1989 Feb; 49(3):681-6. PubMed ID: 2910488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of c-myc and transforming growth factor-alpha messenger RNA expression in poorly differentiated and well-differentiated colon carcinoma cells during the establishment of a quiescent state.
    Mulder KM
    Cancer Res; 1991 May; 51(9):2256-62. PubMed ID: 2015589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
    Ohannesian DW; Lotan D; Lotan R
    Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line.
    Hoosein NM; Brattain DE; McKnight MK; Levine AE; Brattain MG
    Cancer Res; 1987 Jun; 47(11):2950-4. PubMed ID: 3471320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect.
    Hsu S; Huang F; Friedman E
    J Cell Physiol; 1995 Nov; 165(2):239-45. PubMed ID: 7593201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix.
    Morton DM; Barrack ER
    Cancer Res; 1995 Jun; 55(12):2596-602. PubMed ID: 7780974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N,N-dimethylformamide-induced synthesis of an anti-fibronectin reactive protein in cultured human colon carcinoma cells.
    Marks ME; Ziober BL; Brattain MG
    Cancer Res; 1986 Oct; 46(10):5248-58. PubMed ID: 3756877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of carcinoembryonic antigen and its crossreactive gene products in human colonic adenomas and carcinomas by transforming growth factor-beta.
    Chakrabarty S; Mustain S; Willson JK
    Mol Biother; 1990 Mar; 2(1):27-31. PubMed ID: 2334536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors.
    Zhou GH; Sechrist GL; Periyasamy S; Brattain MG; Mulder KM
    Cancer Res; 1995 May; 55(10):2056-62. PubMed ID: 7743502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular growth modulation. I. Effects of extracellular matrix and tumor cell conditioned medium.
    Hakim AA
    Exp Cell Biol; 1986; 54(4):193-211. PubMed ID: 3023158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.